Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV20 in Children and Adolescents With Autoimmune Rheumatic Diseases
NCT07252791Phase 4Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 20 in pneumococcal infection, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Jan 2026; status: recruiting.
02
Drugs
Prevnar 20
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT07252791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07252791.